Goleta-based Transphorm saw net losses continue to mount in its most recent quarter, according to financial results released Aug. 16. Transphorm, a supplier of gallium nitride power conversion products, reported a loss of $7.1 million, or 17 cents per share, in the first quarter of 2021-22, bigger than its net loss of $6.6 million, or Read More →
A judge from the U.S. International Trade Commission ruled in favor of Santa Barbara based Sonos on Aug. 13, finding that Alphabet Inc’s Google infringed upon five of Sonos’ patents for wireless speakers and related technology. Judge Charles E. Bullock did not give a reason for the decision but the ruling did find that Google Read More →
Sonos delivered a loud earnings beat after the markets closed Aug. 11, as the Santa Barbara-based home sound system producer delivered net income back in the black when the company announced its third quarter 2021 earnings. Sonos generated net income of $17.6 million, or 12 cents per diluted share, for the quarter ended June 30. Read More →
Sientra recorded a net loss in its most recent quarter, missing investor expectations, even as the company’s financials improved, according to financial results released Aug. 10. The Goleta-based breast implant manufacturer reported an $18.5 million loss from continuing operations in the second quarter, or 32 cents per share. The loss was a 40.7% decrease from Read More →
Interlink Electronics, an Irvine-based sensor manufacturer with its primary research and development facility in Camarillo, saw both its revenue and net income rise when it released its financial results for the second quarter of 2021. Net revenue grew 21.3% year-over-year, to $2 million in the second quarter of 2021. Net income also rose to $63,000 Read More →
The Trade Desk continues to find success in 2021, as the Ventura-based advertising technology firm saw huge rises in both revenue and net income when the company announced its financial results for the second quarter on Aug. 9. Co-founder and CEO Jeff Green said the company “significantly surpassed” its own expectations for the quarter ended Read More →
Atara Biotherapeutics swallowed more losses in the second quarter of 2021, as the early-stage company hopes for good news for its tab-cel therapy in early 2022. Atara, an immunotherapy biotech company based in South San Francisco with some of its major operations in Thousand Oaks, had a net loss of $83.7 million in the second Read More →